Financhill
Back

First Trust NASDAQ® ABA Community Bk ETF Vs. Keros Therapeutics Industry Stock Comparison

Sell
35

QABA
First Trust NASDAQ® ABA Community Bk ETF

Last Price:
43.96
Seasonality Move:
-0.61%
Sell
25

KROS
Keros Therapeutics

Last Price:
45.20
Seasonality Move:
4.22%
Sell
35
First Trust NASDAQ® ABA Community Bk ETF (QABA) is a Sell

Is First Trust NASDAQ® ABA Community Bk ETF a Buy, Sell or Hold?

  • The current First Trust NASDAQ® ABA Community Bk ETF [QABA] share price is $44.24. The Score for QABA is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • QABA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
Keros Therapeutics (KROS) is a Sell

Is Keros Therapeutics a Buy, Sell or Hold?

  • The current Keros Therapeutics [KROS] share price is $45.65. The Score for KROS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • KROS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QABA Stock Price Chart

What is First Trust NASDAQ® ABA Community Bk ETF's stock price today?

  • The First Trust NASDAQ® ABA Community Bk ETF share price today is $44.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and QABA is experiencing selling pressure, which indicates risk of future bearish movement.

KROS Stock Price Chart

What is Keros Therapeutics's stock price today?

  • The Keros Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and KROS is experiencing slight selling pressure.

QABA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.32 Sell
Relative Strength Index (14 RSI): 47.37 Sell
Chaikin Money Flow: -4798 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (43.64 - 45.56) Sell
Bollinger Bands (100): (43.94 - 46.12) Sell

KROS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.91 Sell
Relative Strength Index (14 RSI): 36.74 Sell
Chaikin Money Flow: -120480 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.18 - 50.06) Sell
Bollinger Bands (100): (50.42 - 64.92) Sell

QABA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.02 Buy
20-day SMA: 44.2 Buy
50-day SMA: 44.97 Sell
200-day SMA: 44.31 Sell
8-day EMA: 44.17 Buy
20-day EMA: 44.39 Sell
50-day EMA: 44.82 Sell
200-day EMA: 44.94 Sell

KROS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 46.5 Sell
20-day SMA: 47.57 Sell
50-day SMA: 52.43 Sell
200-day SMA: 46.94 Sell
8-day EMA: 46.46 Sell
20-day EMA: 48 Sell
50-day EMA: 51.59 Sell
200-day EMA: 50.14 Sell

First Trust NASDAQ® ABA Community Bk ETF Earnings Growth & QABA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Keros Therapeutics Earnings Growth & KROS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

First Trust NASDAQ® ABA Community Bk ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Keros Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):